Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics Revenue

Plus Therapeutics had revenue of $1.03M in the quarter ending March 31, 2026, a decrease of -2.93%. This brings the company's revenue in the last twelve months to $5.18M, down -0.46% year-over-year. In the year 2025, Plus Therapeutics had annual revenue of $5.21M, down -10.49%.

• Revenue (ttm): $5.18M
• Revenue Growth: -0.46%
• P/S Ratio: 7.66
• Revenue / Employee: $186,179
• Employees: 28
• Market Cap: 39.94M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.21M	-611.00K	-10.49%
Dec 31, 2024	5.82M	911.00K	18.54%
Dec 31, 2023	4.91M	4.69M	2,093.30%
Dec 31, 2022	224.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	303.00K	-6.70M	-95.67%
Dec 31, 2019	7.00M	4.02M	134.60%
Dec 31, 2018	2.98M	-739.00K	-19.85%
Dec 31, 2017	3.72M	-3.00M	-44.65%
Dec 31, 2016	6.72M	-97.00K	-1.42%
Dec 31, 2015	6.82M	4.18M	157.88%
Dec 31, 2014	2.65M	-2.43M	-47.87%
Dec 31, 2013	5.07M	-718.00K	-12.40%
Dec 31, 2012	5.79M	3.78M	187.73%
Dec 31, 2011	2.01M	-360.00K	-15.17%
Dec 31, 2010	2.37M	-6.52M	-73.32%
Dec 31, 2009	8.89M	6.57M	282.49%
Dec 31, 2008	2.33M	-2.93M	-55.77%
Dec 31, 2007	5.26M	-1.22M	-18.82%
Dec 31, 2006	6.48M	6.11M	1,645.55%
Dec 31, 2005	371.00K	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error